Compare JD & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JD | ILMN |
|---|---|---|
| Founded | 2006 | 1998 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.2B | 37.0B |
| IPO Year | 2014 | 2000 |
| Metric | JD | ILMN |
|---|---|---|
| Price | $26.49 | $270.57 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 11 | 17 |
| Target Price | $39.27 | ★ $124.24 |
| AVG Volume (30 Days) | ★ 5.4M | 2.2M |
| Earning Date | 05-12-2026 | 04-30-2026 |
| Dividend Yield | ★ 3.37% | N/A |
| EPS Growth | N/A | ★ 170.87 |
| EPS | N/A | ★ 2.22 |
| Revenue | N/A | ★ $4,343,000,000.00 |
| Revenue This Year | $8.17 | $6.47 |
| Revenue Next Year | $6.01 | $5.58 |
| P/E Ratio | ★ $9.17 | $123.38 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $24.51 | $88.00 |
| 52 Week High | $36.86 | $277.95 |
| Indicator | JD | ILMN |
|---|---|---|
| Relative Strength Index (RSI) | 33.32 | 77.89 |
| Support Level | $24.53 | $116.43 |
| Resistance Level | $27.63 | N/A |
| Average True Range (ATR) | 0.39 | 11.84 |
| MACD | 0.04 | 5.39 |
| Stochastic Oscillator | 8.11 | 97.23 |
JD.com is the third-largest Chinese e-commerce platform by gross merchandise volume in 2025. It offers a wide selection of authentic products with speedy and reliable delivery. The company has built its own nationwide fulfilment infrastructure and last-mile delivery network, staffed by its own employees, which supports both its online direct sales, its online marketplace, and omnichannel businesses.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.